ReviewPhysiologia plantarum
A Brief History of Canola Genetic Gains: From Classical Breeding to Genome Editing.
Review in Physiologia plantarum. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Assessment of genetically modified RF3 Canola Quality (CQ)EFSA journal. European Food Safety Authority · 2026Article
- Structural basis of glucosinolate recognition and polyspecific transport by the glucosinolate transporter GTR1.The Journal of biological chemistry · 2026Article
- A Brief History of Canola Genetic Gains: From Classical Breeding to Genome Editing.Physiologia plantarumReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Canola exemplifies the transformation of a crop from industrial use to a globally significant edible oilseed through sustained genetic and biotechnological innovation. Historically, rapeseed was characterized by high erucic acid and glucosinolate contents, restricting its use primarily to industrial applications. However, classical breeding efforts in the 1970s successfully developed 'double-low' canola varieties, significantly reducing erucic acid and glucosinolate levels, thus establishing canola as a safe and nutritious food-grade oil. Subsequent advancements, including the introduction of hybrid cultivars, markedly enhanced seed yields, while mutation breeding and marker-assisted selection refined key agronomic traits such as lodging tolerance and disease resistance. Later, biotechnology breakthroughs expanded canola's versatility, leading to specialty oils with tailored fatty-acid profiles, for example, high-laurate oils for industrial applications and omega-3 enriched oils for nutritional purposes, as well as herbicide-tolerant cultivars that simplified weed management. More recently, genome-editing technologies, notably CRISPR/Cas9, have accelerated trait improvement by precisely modifying oil composition and significantly enhancing pod shatter resistance. This review synthesizes major genetic and breeding milestones that collectively shaped modern canola, highlights ongoing challenges associated with its complex polyploid genome, and discusses how emerging approaches, including multi-omics integration, precision genome editing, and artificial intelligence, offer promising strategies to further enhance canola productivity and sustainability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.